The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section. (NCT05879536) | Clinical Trial Compass
CompletedNot Applicable
The Effect of Intravenous Infusion of Tramadol-ondansetron on Recovery After Caesarean Section.
Spain312 participantsStarted 2023-05-23
Plain-language summary
It will be a prospective observational cohort study. The investigators will compare post-cesarean section recovery in patients receiving intravenous infusion of tramadol-ondansetron versus epidural catheter with infusion of local anesthetics.
Who can participate
Age range18 Years ā 50 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Woman over 18 years old undergoing caesarean section
* She agrees to participate voluntarily.
* She is already receiving any of the analgesic strategies studied.
Exclusion Criteria:
* Receiving an analgesic medication other than the one mentioned as "routine multimodal analgesia" (either as regular medication or for acute post-surgical pain)
* Medical history that determines the baseline data of the scales and data that we collect ( pain or previous disabilities; addiction to drugs, alcohol or drugs; another disease that worsens the quality of life)
* Medical history that conditions the pharmacological effect (allergy, intolerance or atypical reaction to any of the drugs involved in its treatment or possible cross-reactions )
* Contraindication for neuraxial techniques (patient refusal, difficulty in understanding or communication, localized infection, increased intracranial pressure, or other medical criteria)
* Two or more previous caesarean sections
* Difficulty in understanding or communication
* Mother care will not be available to the newborn in the postpartum period for any reason